PROSER2: A Protein Targeted in Cancer, Neurodegenerative Diseases and Psychiatric Disorders

Target Name: PROSER2

NCBI ID: G254427

PROSER2

Other Name(s): PRSR2_HUMAN | proline and serine rich 2 | C10orf47 | Proline and serine-rich protein 2 | Proline and serine rich 2

PROSER2: A Protein Targeted in Cancer, Neurodegenerative Diseases and Psychiatric Disorders

PROSER2 (PRSR2_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, and kidneys. It is a key regulator of the cell cycle, and its levels have been linked to the development and progression of various diseases, including cancer.

Research has also suggested that PROSER2 may have potential as a drug target or biomarker. For example, studies have shown that inhibiting PROSER2 can lead to a reduction in cancer cell proliferation and migration. Additionally, PROSER2 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's.

One potential mechanism by which PROSER2 may be involved in these diseases is by regulating the activity of cells involved in the production of neurotransmitters, such as dopamine and insulin. Studies have shown that PROSER2 is involved in the production of these molecules, and that its activity can be affected by drugs that target the neurotransmitter system.

Another potential mechanism by which PROSER2 may be involved in the development of neurodegenerative diseases is by regulating the activity of immune cells. Studies have shown that PROSER2 is involved in the regulation of immune cell function, and that its activity can be influenced by factors such as inflammation and stress.

In addition to its potential as a drug target or biomarker, PROSER2 is also of interest as a potential therapeutic agent for the treatment of various psychiatric and neurological disorders. Studies have shown that PROSER2 is involved in the development of several mental health conditions, including depression and anxiety. Additionally, PROSER2 has been shown to be involved in the regulation of brain development and plasticity, which may make it a promising target for the development of drugs that can promote brain health and repair.

Overall, PROSER2 is a protein that has significant interest in the development and progression of various diseases, including cancer, neurodegenerative diseases, and psychiatric and neurological disorders. Further research is needed to fully understand its role in these processes and to develop effective therapies that can target it.

Protein Name: Proline And Serine Rich 2

The "PROSER2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PROSER2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets